Please assess the completion status of the following clinical trial:

Trial Title: Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* healthy women~* singleton pregnancy~* caesarean section under regional anaesthesia~* older than 18 years~* written informed consent~Exclusion Criteria:~* emergency caesarean section~* secondary caesarean section due to fetal distress~* comorbidities (cardiovascular, kidney or liver disorder, epilepsy)~* obstetric diseases (hypertension, (pre-)eclampsia)~* uterine malformation (including uterine fibroids)~* bleeding disorder~* known hypersensitivity to carbetocin or oxytocin~* fetal malformation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 46 Years
- Healthy Volunteers: f

Study Arms:
- Short infusion (Type: EXPERIMENTAL): Carbetocin 100 microgram will be applied intravenously in a short infusion over about a minute
- Bolus application (Type: OTHER): Carbetocin 100 microgram will be applied intravenously by bolus application over about 15 seconds

Based on this trial design, predict the completion outcome and termination type (if applicable).